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elsinki and Kuopio, Finland
ong-term occurrence of coronary risk factors, especially in-
reased serum total and low-density lipoprotein cholesterol
oncentration, results in impaired endothelial function through
slow accumulation of lipids, mainly of cholesterol, to arterial
ndothelium (1) developing finally over decades to atheroma
ormation. That the increased serum cholesterol concentra-
ion is one of the most important risk factors of atheroscle-
osis is indicated by several clinical prevention trials showing
hat effective reduction of serum cholesterol by statins
revents subsequent clinical manifestations and can even
egress coronary atheromatosis (2). Diet contains normally
mall amounts, about 300 mg/day, of plant sterols, mainly
itosterol and campesterol, of which less than 5% are
bsorbed. In addition, diet contains even smaller amounts of
lant stanols, about 20 mg/day, which are the saturated
orms of plant sterols, and their absorption is less than 0.5%.
See page 1553
ccordingly, human sera contains normally small amounts
f plant sterols and almost undetectable amounts of plant
tanols derived from diet (3). Dietary plant sterols and
tanols can be enriched in food such as fatty acid esters. The
ommercially available phytosterol ester-enriched spreads
ontain enough plant sterols and stanols so that it is possible
o get the recommended daily intake of plant stanols and
terols, which is 2 g/day. The consumption of this amount
s known to prevent cholesterol absorption and subsequently
ower serum cholesterol concentration (3), and they have
idely been recommended as a population strategy for
reatment of hypercholesterolemia. The difference between
he consumption of enriched amounts of plant stanol or
terol esters is that plant stanols decrease not only the serum
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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uopio, and the Department of Medicine, Kuopio University Hospital, Kuopio, Finland.evel of cholesterol but also that of plant sterols, whereas the
onsumption of plant sterols doubles their serum levels. No
cientific data are available to determine whether the use of
iet-enriched plant stanol or sterol esters in humans could
revent the development of coronary artery disease or athero-
clerosis in general. However, recent studies have shown signs
f improved endothelial function with plant sterol and stanol
ster consumption (4,5). In this issue of the Journal, a mixture
f mice and human studies shows that increased consumption
f plant sterol esters could alter arterial function in mice and
ncrease plant sterol concentration in human aortic valves (6).
lant sterol ester consumption in mice. Plant sterol ester
upplementation to wild-type mice increased their plant
terol but not cholesterol levels in plasma; endothelial
unction was impaired and experimental cerebral lesion size
as increased. These findings can be interpreted to indicate
he harmfulness of the increased plasma plant sterol con-
entrations. It should be kept in mind that high serum plant
terol concentrations in humans with familial phytosterol-
mia are known to cause severe premature atherosclerosis.
n addition, in home-dwelling 75-year-old elders, recur-
ences of major cardiovascular events were increased in
hose with highest versus lowest serum sitosterol ratios to
holesterol during a 3- to 4-year follow-up (7). In fact,
everal clinical studies have actually shown some association
etween serum plant sterols and coronary artery disease in
onphytosterolemic subjects (3), but in recent epidemiolog-
cal studies the association is questioned (8–10).
Additional studies were performed by the investigators with
polipoprotein E/ mice on Western-type diet with plant
terol esters and ezetimibe (6). The latter drug, too, inhibits
holesterol absorption and lowers plasma cholesterol and plant
terol levels. The diet resulted in a marked atheroma formation
n aortic root, which was reduced by the addition of either
lant sterol esters or ezetimibe. However, the size of the
laques was larger on diet plant sterol esters than on diet
zetimibe (20.4  2.1% vs. 10.0  1.5%). Because plasma
holesterol concentrations were similar, the finding was inter-
reted to result from the higher plasma plant sterol concen-
rations. Similar results were obtained in mice on normal chow
ith low dietary cholesterol. The most pronounced reduction
f lesion size was obtained during ezetimibe treatment as
ompared with plant sterol esters with comparable plasma
holesterol levels. The investigators could not show any corre-
ation of plasma cholesterol concentration with plaque size, but
lasma plant sterol levels were positively related to the lesion
ize. Thus, the major observation of the present study was that
or different test conditions the increased plasma plant sterol
oncentrations were associated with enhanced atheroma size,
hich could not be explained with plasma cholesterol concen-
ration. A question now arises: what will happen if plant sterols
onsumed were not absorbed, and their serum levels were not
ncreased but even reduced? In fact, supplementation of plant
terols and stanols, known to cause respective increase and
ecrease in plasma plant sterols, to human subjects, or
a
c
b
H
c
t
i
v
a
a
l
r
T
l
p
s
s
c
i
i
a
r
s
w
w
s
o
t
w
t
T
i
p
w
e
w
h
v
s
s
a
a
c
e
b
p
h
s
p
c
c
p
(
a
a
p
s
m
d
b
t
C
a
e
c
w
w
i
r
c
p
p
c
a
R
B
H
R
1
1
1
1
1
1563JACC Vol. 51, No. 16, 2008 Miettinen and Gylling
April 22, 2008:1562–3 Editorial Commentpolipoprotein-E-deficient mice suggested that the decrease of
holesterol reduces atherosclerosis despite some increase in
lood plant sterol contents (4,11).
uman studies. The investigators evaluated whether in-
reased plant sterol consumption in humans resulted in
issue accumulation of plant sterols (6). For the tissue of
nterest, they selected aortic valves washed from both
entricular and aortic sides by bloodstream lipoproteins. In
recent study, nonrheumatic aortic valve stenosis resembled
therosclerosis of arterial wall including inflammatory cells,
ipoproteins, and calcified nodules (12). Accordingly, the
isk factors of aortic stenosis include those of atherosclerosis.
he investigators studied sterol composition (cholesterol,
athosterol, and plant sterols campesterol and sitosterol) of
lasma and aortic valve cusps from 82 patients undergoing
elective aortic valve replacement. Almost 40% of the
ubjects were on statins. Only 6 of the patients had
onsumed plant sterol ester supplementation regularly and 4
rregularly. No direct measurement of dietary plant sterol
ntake was performed, but the consumption was categorized
ccording to patient questionnaires as none, irregular, or
egular. The concentrations and ratios to cholesterol of plant
terols were related in plasma to those of aortic cusps in the
hole study population. The high correlation (p  0.0001)
as mainly determined by individuals not using plant sterol
upplementation (n 72). However, despite the small number
f plant sterol consumers (only 10%) and the wide variation of
heir plasma and aortic cusp plant sterol levels, the correlation
as higher in regular consumers than in nonconsumers, and
he irregular consumer values fell to the nonconsumer area.
he results indicate that the increase in plasma plant sterols by
ncreased dietary consumption increases proportionately the
lant sterol levels in cusps. Even though no actual attempts
ere made for dietary plant sterol measurement, historical
stimation of the intake suggested that the higher the intake
as, the higher the serum level of plant sterols was, and the
igher the plant sterol content was in tissues including aortic
alve cusps. This type of conclusion has been made in an earlier
tudy (13) that analyzed plant sterols in human sera and in
urgically removed carotid artery plaques. Because the stenotic
ortic valve cusps are frequently filled by atheromatous plaques,
nd even calcifications, which increases their cholesterol con-
entration (12), it is difficult to conclude what is the additional
ffect, if any, of increased minor amounts of plant sterols.
As pointed out by the investigators, the study is limited
y retrospective design and small number of subjects on
lant sterol esters. In addition, further information could
ave been obtained if, in addition to plant sterols, plant
tanol esters had been used, because by decreasing serum
lant sterols they could have had a similar action on aortic
usp sterols. Diets enriched with plant stanols lower serum
holesterol and plant sterols and slightly increase serum
lant stanols, yet they may improve arterial function
4,5,14). The investigators performed microscopic studies in
nimal experiments, but no histology was given for human
ortic cusps. Accordingly, the pathogenic contribution oflant sterols to aortic valve stenosis remains open. A recent
tudy has revealed that in stenotic aortic valves novel
echanisms of inflammation, fibrosis, and elastin fiber
egradation can be detected (12), suggesting that they may
e pathogenetic factors of the stenosis and may offer a new
arget for medical therapy.
onclusions. Several experimental studies in normal and
polipoprotein-E-deficient mice in the study by Weingärtner
t al. (6) indicated that the increase in serum plant sterol
ontents with diet-enriched plant sterol ester consumption
orsens arterial function. Humans consuming a diet enriched
ith plant sterol esters had increased contents of plant sterols
n serum and in atherosclerotic aortic valves. However, it
emains open whether high plant sterol levels in aortic valves
ause atherosclerosis. Even though excessively increased serum
lant sterols in serum of sitosterolemic patients with mutated
lant sterol metabolism can result in early atheromatosis, no
onsistent association is available with serum plant sterols and
theromatosis under normal conditions.
eprint requests and correspondence: Dr. Tatu A. Miettinen,
iomedicum Helsinki, Room C4 22, P.O. Box 700, FIN-00029
US, Finland. E-mail: tatu.a.miettinen@helsinki.fi.
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